α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Por um escritor misterioso

Last updated 04 setembro 2024

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

Influence of pH on the uptake and toxicity of β-blockers in embryos of zebrafish, Danio rerio - ScienceDirect

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes

Modulation of β-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action - ScienceDirect

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery - ScienceDirect

Updates in the function and regulation of α1‐adrenoceptors - Akinaga - 2019 - British Journal of Pharmacology - Wiley Online Library

Recomendado para você